These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2846096)
21. The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Piët MP; Chin S; Prince AM; Brotman B; Cundell AM; Horowitz B Transfusion; 1990 Sep; 30(7):591-8. PubMed ID: 2402772 [TBL] [Abstract][Full Text] [Related]
22. Virus reduction in an intravenous immunoglobulin by solvent/detergent treatment, ion-exchange chromatography and terminal low pH incubation. Roberts PL; Dunkerley C; Walker C Biologicals; 2012 Sep; 40(5):345-52. PubMed ID: 22658506 [TBL] [Abstract][Full Text] [Related]
23. Inactivation of viruses by pasteurization at 60 °C for 10 h with and without 40% glucose as stabilizer during a new manufacturing process of α2-Macroglobulin from Cohn Fraction IV. Huangfu C; Ma Y; Jia J; Lv M; Zhu F; Ma X; Zhao X; Zhang J Biologicals; 2017 Mar; 46():139-142. PubMed ID: 28215695 [TBL] [Abstract][Full Text] [Related]
24. Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate. Roberts PL; Dunkerley C Vox Sang; 2003 Apr; 84(3):170-5. PubMed ID: 12670365 [TBL] [Abstract][Full Text] [Related]
25. Large-scale gel filtration chromatography for the production of a solvent/detergent-treated high-purity factor VIII concentrate. Dengler T; Stöcker U; Kellner S; Fürst G Vox Sang; 1990; 58(4):257-63. PubMed ID: 1697997 [TBL] [Abstract][Full Text] [Related]
26. Purification of fibroblast growth factor-2 from human placenta using tri(n-butyl)phosphate and sodium cholate. Wolff P; Tanaka AM; Chenker E; Cabrera-Crespo J; Raw I; Ho PL Biochimie; 1996; 78(3):190-4. PubMed ID: 8831950 [TBL] [Abstract][Full Text] [Related]
27. Quantitative determination of residual sodium-cholate in tri(N-butyl)phosphate/sodium-cholate treated factor VIII-preparations. Dengler T; Kellner S; Fürst G Vox Sang; 1989; 57(3):161-3. PubMed ID: 2515653 [TBL] [Abstract][Full Text] [Related]
28. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb). Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615 [TBL] [Abstract][Full Text] [Related]
29. The purification of hemoglobin solutions by heating. Estep TN; Bechtel MK; Bush SL; Miller TJ; Szeto S; Webb LE Prog Clin Biol Res; 1989; 319():325-36; discussion 337-8. PubMed ID: 2560198 [No Abstract] [Full Text] [Related]
30. Quantitative assays for evaluation of HTLV-III inactivation procedures: tri(N-butyl)phosphate:sodium cholate and beta-propiolactone. Prince AM; Horowitz B; Dichtelmueller H; Stephan W; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4592s-4594s. PubMed ID: 2410108 [TBL] [Abstract][Full Text] [Related]
31. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids. Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Virus Reduction by Ultrafiltration with Coagulation-Sedimentation in Water Reclamation. Lee S; Hata A; Yamashita N; Tanaka H Food Environ Virol; 2017 Dec; 9(4):453-463. PubMed ID: 28455611 [TBL] [Abstract][Full Text] [Related]
33. Estimation of efficiency of solvent-detergent method for virus inactivation in the technology of immunoglobulin production on the model of duck hepatitis B virus. Zubkova NV; Anastasiev VV; Kyuregyan KK; Mikhailov MI; Lobastova AK; Krasil'nikov IV Bull Exp Biol Med; 2013 Oct; 155(6):821-4. PubMed ID: 24288775 [TBL] [Abstract][Full Text] [Related]
34. Removal of small non-enveloped viruses by nanofiltration. Yokoyama T; Murai K; Murozuka T; Wakisaka A; Tanifuji M; Fujii N; Tomono T Vox Sang; 2004 May; 86(4):225-9. PubMed ID: 15144526 [TBL] [Abstract][Full Text] [Related]
35. Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin. Farmer M; Ebeling A; Marshall T; Hauck W; Sun CS; White E; Long Z Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):429-33. PubMed ID: 1327242 [TBL] [Abstract][Full Text] [Related]
36. Cheddar cheese as a vehicle for viruses. Cliver DO J Dairy Sci; 1973 Oct; 56(10):1329-31. PubMed ID: 4355048 [No Abstract] [Full Text] [Related]
37. [Viral validation of the bio-globulin production process]. Zahorska R; Buchowicz I Med Dosw Mikrobiol; 1995; 47(1-2):89-94. PubMed ID: 8523973 [TBL] [Abstract][Full Text] [Related]
39. Sindbis virus as a tool for quality control of viral inactivation of heated and chemically treated plasma-derived products. Espíndola OM; Belluci MS; Oliveira BC; Liberto MI; Cabral MC J Virol Methods; 2006 Jun; 134(1-2):171-5. PubMed ID: 16507321 [TBL] [Abstract][Full Text] [Related]
40. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII. Roberts PL Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]